The most widely accepted treatment for cutaneous angiosarcoma (CAS) is wide local
excision and postoperative radiation to decrease the risk of recurrence. Positive surgical …

Background Angiosarcoma of the scalp and face is an aggressive tumor with a high rate of
local recurrence. Although many previous studies have demonstrated risk factors for poor …

Background Angiosarcomas are tumors of malignant endothelial origin that have a poor
prognosis with a five-year survival of less than 40%. These tumors can be found in all age …

Purpose This study reports the first-in-human use of a linear accelerator-based boron
neutron capture therapy (BNCT) system and the first treatment of patients with scalp …

Simple Summary Cutaneous angiosarcoma (CAS) is a rare sarcoma with dismal prognosis.
To better characterize this disease and elucidate potential treatments that improve overall …

Head and neck angiosarcomas (HN-AS) are rare malignancies with a poor prognosis
relative to other soft tissue sarcomas. To date, the HN-AS literature has been limited to short …

Background The primary purpose of this study was to examine whether angiosarcoma
outcomes differ for the scalp and face. Methods We conducted a retrospective outcomes …

Angiosarcomas (AS) are a diverse group of soft tissue sarcomas, arising from blood and
lymphatic vessels. They frequently present in the elderly, and in patients with previous …

Angiosarcoma is a rare endothelial-derived malignancy that is extremely diverse in
anatomy, aetiology, molecular and immune characteristics. While novel therapeutic …

Angiosarcoma, a rare cutaneous malignancy, frequently arises in the scalp of older
individuals. Because it characteristically initially mimics benign disease, such as a bruise …